Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

IRIDEX Corporation - Common Stock (NQ:IRIX)

0.9600 -0.0700 (-6.80%)
Streaming Delayed Price Updated: 1:54 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IRIDEX Corporation - Common Stock

< Previous 1 2 3 4 Next >
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Iridex Reports Fourth Quarter and Full Year 2024 Financial Results
From IRIDEX Corporation
Via GlobeNewswire
Earnings Preview For Iridex
Via Benzinga
Iridex Announces Strategic Investment in the Company
From IRIDEX Corporation
Via GlobeNewswire
Earnings Scheduled For November 12, 2024
Via Benzinga
Insights into Iridex's Upcoming Earnings
Via Benzinga
Iridex: Q4 Earnings Insights
Via Benzinga
Earnings Scheduled For March 27, 2025
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Iridex Comments on Recent Stock Price Volatility
From IRIDEX Corporation
Via GlobeNewswire
Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025
From IRIDEX Corporation
Via GlobeNewswire
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2024
From IRIDEX Corporation
Via GlobeNewswire
Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management
From IRIDEX Corporation
Via GlobeNewswire
Iridex Comments on Changing Glaucoma Reimbursement Landscape
From IRIDEX Corporation
Via GlobeNewswire
Iridex Reports Third Quarter 2024 Financial Results
From IRIDEX Corporation
Via GlobeNewswire
Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024
From IRIDEX Corporation
Via GlobeNewswire
Iridex Appoints Patrick Mercer as Chief Executive Officer
From IRIDEX Corporation
Via GlobeNewswire
IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q2 2024
IRIX stock results show that Iridex missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Iridex Reports Second Quarter 2024 Financial Results
From IRIDEX Corporation
Via GlobeNewswire
Iridex Announces Convertible Note Financing
From IRIDEX Corporation
Via GlobeNewswire
Iridex to Report Second Quarter 2024 Financial Results on August 8, 2024
From IRIDEX Corporation
Via GlobeNewswire
IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q1 2024
IRIX stock results show that Iridex missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Iridex Reports First Quarter 2024 Financial Results
From IRIDEX Corporation
Via GlobeNewswire
Iridex to Report First Quarter 2024 Financial Results on May 14, 2024
From IRIDEX Corporation
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q4 2023
IRIX stock results show that Iridex missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Iridex Reports Fourth Quarter and Full Year 2023 Financial Results
Advances strategic review to unlock shareholder value 
From IRIDEX Corporation
Via GlobeNewswire
Earnings Scheduled For March 26, 2024
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million. 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.